← Evidence map

ArticleDiscover oncology2025

PRSS53 is a potential novel biomarker related to prognosis and immunity in clear cell renal cell carcinoma.

Jiajun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40111561